Log in

OTCMKTS:TBPMF - Tetra Bio Pharma Stock Price, Forecast & News

-0.01 (-1.79 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
Now: $0.39
50-Day Range
MA: $0.22
52-Week Range
Now: $0.39
Volume84,355 shs
Average Volume79,117 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Tetra Bio-Pharma Inc., a development stage company, engages in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements in Canada. Its lead product is PPP001, a dried cannabis prescription drug for advanced cancer pain. The company is also developing other cannabis-based drugs for pain management; a series natural health products, including a topical product for pain management; an oral product line for cardiovascular disease prevention, athletic performance, and well-being; a topical product for skin care; a topical product for women; and Munchies B Gone gum. It has collaboration agreements with Algorithme Pharma, Inc.; Aphria Inc.; IntelGenx Corp.; McGill University; Panag Pharma Inc.; the University of New Brunswick; and Ovensa Inc. The company was formerly known as GrowPros Cannabis Ventures Inc. and changed its name to Tetra Bio-Pharma Inc. in September 2016. Tetra Bio-Pharma Inc. is headquartered in Longueuil, Canada.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive TBPMF News and Ratings via Email

Sign-up to receive the latest news and ratings for TBPMF and its competitors with MarketBeat's FREE daily newsletter.

Tetra Bio Pharma (OTCMKTS:TBPMF) Frequently Asked Questions

What is Tetra Bio Pharma's stock symbol?

Tetra Bio Pharma trades on the OTCMKTS under the ticker symbol "TBPMF."

Has Tetra Bio Pharma been receiving favorable news coverage?

Headlines about TBPMF stock have been trending somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tetra Bio Pharma earned a media sentiment score of -1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Tetra Bio Pharma.

Who are some of Tetra Bio Pharma's key competitors?

What other stocks do shareholders of Tetra Bio Pharma own?

Who are Tetra Bio Pharma's key executives?

Tetra Bio Pharma's management team includes the folowing people:
  • Dr. Guy Chamberland M.Sc., Master Herbal, Ph.D., Co-Founder, CEO & Chief Scientific Officer (Age 57)
  • Mr. André Rancourt, Co-Founder
  • Mr. Sabino Roberto Di Paola C.A., CPA, CPA, CA, Chief Financial Officer (Age 41)
  • Jennifer McCaughey, VP of Investor Relations
  • Mr. Robert Bechard, Exec. VP of Corp. Devel. & Licensing (Age 60)

How do I buy shares of Tetra Bio Pharma?

Shares of TBPMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tetra Bio Pharma's stock price today?

One share of TBPMF stock can currently be purchased for approximately $0.39.

What is Tetra Bio Pharma's official website?

The official website for Tetra Bio Pharma is http://www.tetrabiopharma.com/.

How can I contact Tetra Bio Pharma?

The company can be reached via phone at 343-780-2020.

MarketBeat Community Rating for Tetra Bio Pharma (OTCMKTS TBPMF)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  21
MarketBeat's community ratings are surveys of what our community members think about Tetra Bio Pharma and other stocks. Vote "Outperform" if you believe TBPMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TBPMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel